Suicides by violent means in individuals taking SSRIs and other antidepressants - A postmortem study in Sweden, 1992-2004

被引:22
作者
Fazel, Seena
Grann, Martin
Ahlner, Johan
Goodwin, Guy
机构
[1] Univ Oxford, Dept Psychiat, Oxford OX3 7JX, England
[2] Karolinska Inst, Ctr Violence Prevent, Stockholm, Sweden
[3] Linkoping Univ Hosp, Dept Forens Toxicol, S-58185 Linkoping, Sweden
关键词
D O I
10.1097/jcp.0b013e31814ce3ef
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A number of reports have linked consumption of selective serotonin reuptake inhibitors (SSRIs) with suicide by violent methods. We aimed to determine whether suicides with postmortem evidence of SSRI consumption are more likely to have used violent methods compared with suicides with no detectable antidepressants. Blood samples from all suicides in Sweden during 1992-2004 were examined. Suicides were classified into those who died by violence and nonviolent (self-poisoning) methods using information from police records and autopsy. In addition, we investigated proportions of violent suicide in individuals who died with detectable levels of tricyclic and other antidepressants. The sample consisted of 14,691 suicides. Of the 1958 suicides with detectable levels of SSRIs, 1247 were by violent means (63.7%) compared with 7835 of 11,045 suicides (70.9%) in antidepressant-free group (chi(2)(1) = 7.6; P < 0.01). We found no significant differences in the proportion of violent suicides, in the SSRI group compared with the antidepressant-free group by sex or age band (15-24, 25-39, and over 40 years). When subdivided by gender and age-bands, we found specific groups with significantly lower proportions of violent suicides compared with the antidepressants-free group, including men aged 15-24 years.
引用
收藏
页码:503 / 506
页数:4
相关论文
共 20 条
[1]   Duloxetine - Meta-analyses of suicidal behaviors and ideation in clinical trials for major depressive disorder [J].
Acharya, Nayan ;
Rosen, Amy S. ;
Polzer, John P. ;
D'Souza, Deborah N. ;
Perahia, David G. ;
Cavazzoni, Patrizia A. ;
Baldessarini, Ross J. .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2006, 26 (06) :587-594
[2]   Psychopharmacological treatment and psychiatric morbidity in 390 cases of suicide with special focus on affective disorders [J].
Andersen, UA ;
Anderson, M ;
Rosholm, JU ;
Gram, LF .
ACTA PSYCHIATRICA SCANDINAVICA, 2001, 104 (06) :458-465
[3]   Suicide after deliberate self-harm: A 4-year cohort study [J].
Cooper, J ;
Kapur, N ;
Webb, R ;
Lawlor, M ;
Guthrie, E ;
Mackway-Jones, K ;
Appleby, L .
AMERICAN JOURNAL OF PSYCHIATRY, 2005, 162 (02) :297-303
[4]  
*CSM EXP WORK GROU, 2004, REP CSM WORK GROUP S
[5]  
Druid H, 1997, J FORENSIC SCI, V42, P79
[6]   Is violent method of suicide a behavioral marker of lifetime aggression? [J].
Dumais, A ;
Lesage, AD ;
Lalovic, A ;
Séguin, M ;
Tousignant, M ;
Chawky, N ;
Turecki, G .
AMERICAN JOURNAL OF PSYCHIATRY, 2005, 162 (07) :1375-1378
[7]   Hostility changes following antidepressant treatment: Relationship to stress and negative thinking [J].
Fava, M ;
Davidson, K ;
Alpert, JE ;
Nierenberg, AA ;
Worthington, J ;
OSullivan, R ;
Rosenbaum, JF .
JOURNAL OF PSYCHIATRIC RESEARCH, 1996, 30 (06) :459-467
[8]   Suicide trends in discharged patients with mood disorders: associations with selective serotonin uptake inhibitors and comorbid substance misuse [J].
Fazel, S ;
Grann, M ;
Goodwin, GM .
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2006, 21 (02) :111-115
[9]   Suicide by antidepressant intoxication identified at autopsy in Vienna from 1991-1997: the favourable consequences of the increasing use of SSRIs [J].
Frey, R ;
Schreinzer, D ;
Stimpfl, T ;
Vycudilik, W ;
Berzlanovich, A ;
Kasper, S .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2000, 10 (02) :133-142
[10]   Suicide rates in short-term randomized controlled trials of newer antidepressants [J].
Hammad, TA ;
Laughren, TP ;
Racoosin, JA .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2006, 26 (02) :203-207